Healthcare Central

  • Sanofi’s FDA Nod in Hemophilia Gives Patients More Convenience, Brings Roche New Competition

    Sanofi’s FDA Nod in Hemophilia Gives Patients More Convenience, Brings Roche New Competition FDA approval of Sanofi hemophilia A drug Altuviiio provides patients with a therapeutic option that lasts longer than most other products available, including one already marketed by the French pharma giant. Altuviiio also gives Sanofi a way to better compete against blockbuster…

  • Industrial Scale Microbiome Mining is a New Drug Discovery Toolbox

    Industrial Scale Microbiome Mining is a New Drug Discovery Toolbox Within ten years of execution and widespread adoption, most pipelines will be traced to the opportunity of untapped microbes of the earth. Information Courtesy By: Ross Youngs, #HealthcareNews #Healthcare | Feeds Within ten years of execution and widespread adoption, most pipelines will be traced to…

  • Improving Value-based Care with Optimized Drug Therapy

    Improving Value-based Care with Optimized Drug Therapy Optimizing drug routines allows prescribers to make more informed decisions that reduce risk and improve quality of care. The result is better outcomes for both patients and organizations. Information Courtesy By: Michael S. Awadalla, #HealthcareNews #Healthcare | Feeds Optimizing drug routines allows prescribers to make more informed decisions…

  • AbbVie Pays Capsida $70M to Expand Gene Therapy Alliance to Eye Diseases

    AbbVie Pays Capsida $70M to Expand Gene Therapy Alliance to Eye Diseases AbbVie and Capsida Therapeutics are expanding their gene therapy R&D alliance to the eyes. Capsida is in line to receive $70 million now and up to $595 million later, depending on the progress of the eye programs. Information Courtesy By: Frank Vinluan, #HealthcareNews…

  • Challenging State Abortion Bans in Light of FDA’s Rule Change on the Sale of Abortion Pills

    Challenging State Abortion Bans in Light of FDA’s Rule Change on the Sale of Abortion Pills The current legal landscape makes access to medication abortion crucial in protecting as much access to reproductive healthcare as possible and in protecting healthcare providers’ abilities to do their jobs without fear of prosecution.  Information Courtesy By: Joanna Wright…

  • Moderna Signs On a New Partner in Quest for In Vivo mRNA Gene Editing

    Moderna Signs On a New Partner in Quest for In Vivo mRNA Gene Editing Moderna is partnering with Life Edit, a subsidiary of ElevateBio that offers a suite of gene-editing technologies. The deal brings together the capabilities of both companies, which aim to develop in vivo gene-editing therapies.Mod Information Courtesy By: Frank Vinluan, #HealthcareNews #Healthcare…

  • Apellis Drug Becomes First Approved Therapy for Vision-Loss Disorder Geographic Atrophy

    Apellis Drug Becomes First Approved Therapy for Vision-Loss Disorder Geographic Atrophy The FDA approved Apellis Pharmaceuticals’ Syfovre as a treatment for geographic atrophy, a retinal disorder that is a leading cause of blindness. The drug, administered as an injection into the eye, will launch in March at the price of $2,190 per vial. Information Courtesy…

Got any book recommendations?

Get In Touch